Breaking News Instant updates and real-time market news.

BA

Boeing

$371.55

4.25 (1.16%)

13:05
11/17/19
11/17
13:05
11/17/19
13:05

Boeing, Biman announce order for two 787-9 Dreamliner jets

Boeing and Biman Bangladesh Airlines announced at the 2019 Dubai Airshow that the carrier is expanding its 787 Dreamliner fleet with two additional airplanes valued at $585M at list prices. The purchase - recorded in October as an unidentified order on Boeing's website - complements Biman's fleet of 787-8 jets with the larger and longer-range 787-9 variant.

BA Boeing
$371.55

4.25 (1.16%)

10/28/19
RHCO
10/28/19
NO CHANGE
Target $49
RHCO
Sell
Barnes Group price target raised to $49 from $45 at SunTrust
SunTrust analyst Michael Ciarmoli raised his price target on Barnes Group to $49 after its Q3 earnings beat that was driven by stronger execution and productivity gains. The analyst maintains his Sell rating on the stock however amid continued industrial sector weakness, also pointing to the management cutting its 2019 outlook due to weak short-cycle industrial demand. Ciarmoli adds that while Barnes group saw further momentum in its Aerospace business, the quarter may have marked a peak with MAX aircraft output rate reduced to 42 per month.
10/28/19
JEFF
10/28/19
NO CHANGE
Target $420
JEFF
Buy
Boeing price target lowered to $420 from $430 at Jefferies
Jefferies analyst Sheila Kahyaoglu lowered her price target for Boeing to $420 from $430 while keeping a Buy rating on the shares. With the MAX potentially re-entering service in early 2020 and stepping up in rate in late 2020, the 787 step down and 777X delay "creates a more balanced production profile," Kahyaoglu tells investors in a research note. The analyst models an average of ~$31 per share in free cash flow per year over 2020 to 2022.
10/29/19
BUCK
10/29/19
NO CHANGE
Target $365
BUCK
Neutral
Boeing price target lowered to $365 from $395 at Buckingham
Buckingham analyst Richard Safran lowered his price target for Boeing to $365 from $395 and reiterated his Neutral view, telling investors in a research note that the MAX will likely get certified in 4Q19 or early 1Q20, and after deliveries start, sentiment should improve as investors gain visibility into when cash flow, capital deployment, and orders return to pre-MAX crisis levels. He sees two scenarios going forward, with a "reasonable" chance for both: 1) book to bill returns to greater than 1x and investors continue to value Boeing based on 15-17x free cash flow estimates that grow $1-$2/share per year off of 2021E $30/share or; 2) traffic growth decelerates, Boeing loses market share, book to bill falls to less than1x, and multiples compress to the historical less than 10-12x peak free cash flow.
10/31/19
BERN
10/31/19
DOWNGRADE
Target $61
BERN
Market Perform
Boeing's MAX re-launch to have large impact on Southwest, says Bernstein
Bernstein analyst David Vernon downgraded Southwest (LUV) to Market Perform from Outperform with a $61 price target. In a research note to investors, the analyst says he thinks the market is pricing in all the good news on the return of Boeing's (BA) MAX and not appreciating how disruptive its return could be on either the unit revenue or cost fronts. Vernon says he thinks Boeing's re-launch of the MAX will have disproportionately large impact on Southwest's own unit revenue and require start-up costs that are difficult to anticipate.

TODAY'S FREE FLY STORIES

PRQR

ProQR Therapeutics

$9.09

0.44 (5.09%)

07:13
12/11/19
12/11
07:13
12/11/19
07:13
Hot Stocks
ProQR Therapeutics doses first patient in Phase 1/2 Aurora trial of QR-1123 »

ProQR Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BTAI

BioXcel Therapeutics

$6.08

-0.07 (-1.14%)

07:12
12/11/19
12/11
07:12
12/11/19
07:12
Hot Stocks
BioXcel Therapeutics to expand BXCL701 study into multiple advanced solid tumors »

BioXcel Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PAA

Plains All American

$18.01

0.49 (2.80%)

07:12
12/11/19
12/11
07:12
12/11/19
07:12
Recommendations
Plains All American analyst commentary  »

Plains All American price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Feb

WSR

Whitestone REIT

$13.66

-0.1 (-0.73%)

07:11
12/11/19
12/11
07:11
12/11/19
07:11
Hot Stocks
Whitestone REIT acquires Las Colina Village, terms not disclosed »

Whitestone REIT acquired…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AFIN

American Finance Trust

$14.53

-0.15 (-1.02%)

07:10
12/11/19
12/11
07:10
12/11/19
07:10
Conference/Events
American Finance Trust management to meet with B. Riley FBR »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

AHCO

AdaptHealth

$10.09

0.19 (1.92%)

07:10
12/11/19
12/11
07:10
12/11/19
07:10
Initiation
AdaptHealth initiated  »

AdaptHealth initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VIE

Viela Bio

$28.00

2 (7.69%)

07:10
12/11/19
12/11
07:10
12/11/19
07:10
Hot Stocks
Viela Bio initiates Phase 2b trial of VIB4920 in Sjogren's syndrome »

Viela Bio announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XCUR

Exicure

$2.99

0.115 (4.01%)

07:09
12/11/19
12/11
07:09
12/11/19
07:09
Hot Stocks
Exicure announces update from AST-008 trial, to enroll patients in Phase 2 study »

Exicure announced an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BCRX

BioCryst

$2.86

0.26 (10.00%)

07:08
12/11/19
12/11
07:08
12/11/19
07:08
Hot Stocks
BioCryst submits NDA for oral, once daily berotralstat for HAE attacks »

BioCryst Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PTI

Proteostasis

$3.96

0.44 (12.50%)

07:08
12/11/19
12/11
07:08
12/11/19
07:08
Hot Stocks
Proteostasis begins trial of proprietary modulators in cystic fibrosis »

Proteostasis announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JOBS

51job

$81.19

1.88 (2.37%)

07:07
12/11/19
12/11
07:07
12/11/19
07:07
Initiation
51job initiated  »

Morgan Stanley starts…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SBRA

Sabra Health Care

$21.87

-0.3 (-1.35%)

07:07
12/11/19
12/11
07:07
12/11/19
07:07
Syndicate
Breaking Syndicate news story on Sabra Health Care »

Sabra Health Care files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PLCE

Children's Place

$70.67

0.68 (0.97%)

07:07
12/11/19
12/11
07:07
12/11/19
07:07
Earnings
Children's Place lowers FY19 adj. EPS view $5.00-$5.20 from $5.40-$5.75 »

Consensus $5.62. Sees…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

UNFI

United Natural Foods

$9.88

0.19 (1.96%)

07:06
12/11/19
12/11
07:06
12/11/19
07:06
Hot Stocks
United Natural Foods reports Q1 gross margin 12.81% of net sales »

Gross margin for the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 18

    Dec

AZO

AutoZone

$1,250.39

79.085 (6.75%)

07:05
12/11/19
12/11
07:05
12/11/19
07:05
Recommendations
AutoZone analyst commentary  »

AutoZone price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 18

    Dec

CORV

Correvio

$1.39

(0.00%)

07:05
12/11/19
12/11
07:05
12/11/19
07:05
Downgrade
Correvio rating change  »

Correvio downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Dec

JBLU

JetBlue

$18.89

-0.03 (-0.16%)

07:04
12/11/19
12/11
07:04
12/11/19
07:04
Hot Stocks
JetBlue reports November traffic up 3.7% »

JetBlue reported its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UNFI

United Natural Foods

$9.88

0.19 (1.96%)

07:04
12/11/19
12/11
07:04
12/11/19
07:04
Hot Stocks
United Natural Foods CEO says 'we remain confident that UNFI is well-positioned' »

"We entered the new…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 18

    Dec

PLCE

Children's Place

$70.67

0.68 (0.97%)

07:04
12/11/19
12/11
07:04
12/11/19
07:04
Earnings
Children's Place sees Q4 adjusted EPS $1.48-$1.68, consensus $2.06 »

Sees Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

UNFI

United Natural Foods

$9.88

0.19 (1.96%)

07:03
12/11/19
12/11
07:03
12/11/19
07:03
Hot Stocks
Breaking Hot Stocks news story on United Natural Foods »

United Natural Foods…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 18

    Dec

STAA

Staar Surgical

$37.19

0.23 (0.62%)

07:03
12/11/19
12/11
07:03
12/11/19
07:03
Hot Stocks
STAAR Surgical announces FDA IDE clinical study approval »

STAAR Surgical is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UNFI

United Natural Foods

$9.88

0.19 (1.96%)

07:02
12/11/19
12/11
07:02
12/11/19
07:02
Earnings
United Natural Foods backs FY20 adjusted EPS view $1.22-$1.76, consensus $1.38 »

Backs FY20 revenue view…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 18

    Dec

FTV

Fortive

$73.83

-0.31 (-0.42%)

07:02
12/11/19
12/11
07:02
12/11/19
07:02
Upgrade
Fortive rating change  »

Fortive upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

PLCE

Children's Place

$70.67

0.68 (0.97%)

07:02
12/11/19
12/11
07:02
12/11/19
07:02
Earnings
Children's Place reports Q3 adjusted EPS $3.03, consensus $3.02 »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

SLG

SL Green Realty

$89.95

1.355 (1.53%)

07:02
12/11/19
12/11
07:02
12/11/19
07:02
Upgrade
SL Green Realty rating change  »

SL Green Realty upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.